Clinical Trial Update: Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial [NA]

View source ↗

Summary

This clinical trial update covers the completed SWIFT PRIME trial evaluating Solitaire thrombectomy as the primary endovascular treatment for acute ischemic str…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Solitaire FR Revascularization Device (Solitaire thrombectomy device)

Snippet

Sponsor: Medtronic Neurovascular Clinical Affairs | Conditions: Acute Ischemic Stroke | NA | Status: COMPLETED | Results posted: 2017-05-18